NEW DELHI: US’ largest diagnostic chain Quest Diagnostic, which set up its office in India recently, is looking at expanding its centres across the country in the next two years to tap the $1-billion diagnostic market. The company also plans to conduct clinical trials of global and Indian pharma companies at its Indian centres.
